These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31336602)

  • 1. The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.
    Rodriguez D; Ramkairsingh M; Lin X; Kapoor A; Major P; Tang D
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.
    Saha T; Lukong KE
    Front Oncol; 2022; 12():856974. PubMed ID: 35392236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Breast Cancer Stem Cells Traits and Drug Resistance.
    Zheng Q; Zhang M; Zhou F; Zhang L; Meng X
    Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion.
    Ojo D; Wei F; Liu Y; Wang E; Zhang H; Lin X; Wong N; Bane A; Tang D
    Curr Med Chem; 2015; 22(19):2360-74. PubMed ID: 25882671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer stem cells: The role of sex steroid receptors.
    Giovannelli P; Di Donato M; Galasso G; Di Zazzo E; Medici N; Bilancio A; Migliaccio A; Castoria G
    World J Stem Cells; 2019 Sep; 11(9):594-603. PubMed ID: 31616537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch Signaling Pathway and Endocrine Resistance in Breast Cancer.
    Bai JW; Wei M; Li JW; Zhang GJ
    Front Pharmacol; 2020; 11():924. PubMed ID: 32636747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-Positive Breast Cancer Following Endocrine Therapy.
    Peiffer DS; Wyatt D; Zlobin A; Piracha A; Ng J; Dingwall AK; Albain KS; Osipo C
    Cancer Res; 2019 Oct; 79(19):4965-4977. PubMed ID: 31387918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
    Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
    Front Oncol; 2020; 10():452. PubMed ID: 32426267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX9/FXYD3/Src Axis Is Critical for ER
    Xue Y; Lai L; Lian W; Tu X; Zhou J; Dong P; Su D; Wang X; Cao X; Chen Y; Wang Q
    Mol Cancer Res; 2019 Jan; 17(1):238-249. PubMed ID: 30206184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
    Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
    Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance.
    Brufsky AM; Dickler MN
    Oncologist; 2018 May; 23(5):528-539. PubMed ID: 29352052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy.
    Howard EW; Yang X
    Biol Proced Online; 2018; 20():17. PubMed ID: 30214383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
    Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
    Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
    Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell in breast cancer therapeutic resistance.
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine therapy and strategies to overcome therapeutic resistance in breast cancer.
    Mancuso MR; Massarweh SA
    Curr Probl Cancer; 2016; 40(2-4):95-105. PubMed ID: 27839747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.
    Massarweh S; Schiff R
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S15-24. PubMed ID: 17259554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?
    Shima H; Yamada A; Ishikawa T; Endo I
    Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
    Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
    Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.